GlobalDeal

Nflection Therapeutics

Biotechnology · Boston, United States

nflection.com

About Nflection Therapeutics

Nflection Therapeutics is a biotechnology company focused on developing innovative therapies for patients with cancer. The company specializes in the discovery and development of novel treatments that target specific cancer pathways, aiming to improve patient outcomes and quality of life. Nflection is committed to advancing its proprietary drug candidates through clinical trials and into the market, leveraging cutting-edge research and technology. The team at Nflection consists of experienced professionals from various fields, including oncology, drug development, and regulatory affairs, working collaboratively to bring new hope to patients facing challenging diagnoses. The company is headquartered in Boston, Massachusetts, a hub for biotechnology and life sciences, which provides access to a rich ecosystem of research institutions and industry partners.

Company facts

Industry
Biotechnology
Sub-industries
Pharmaceuticals, Oncology, Drug Development, Clinical Trials, Biopharmaceuticals
Location
Boston, United States
Employees
11–50
Revenue (USD)
<1M
Founded
2019

Products and services

Open Nflection Therapeutics in GlobalDeal Is this your company? Update the details for free

More Biotechnology companies in United States

All 17,138 Biotechnology companies in United States →